We are live on ! Find out more
SRDX

Surmodics

Delisted

SRDX was delisted on the 18th of November, 2025.

135 hedge funds and large institutions have $362M invested in Surmodics in 2025 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 46 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more call options, than puts

Call options by funds: $989K | Put options by funds: $668K

0.83% less ownership

Funds ownership: 83.82%82.99% (-0.83%)

3% less funds holding

Funds holding: 139135 (-4)

11% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 46

13% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 23

24% less capital invested

Capital invested by funds: $474M → $362M (-$112M)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
135
Holders Change
-4
Holders Change %
-2.88%
% of All Funds
1.81%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
20
Increased
41
Reduced
46
Closed
23
Calls
$989K
Puts
$668K
Net Calls
+$321K
Net Calls Change
-$328K

SRDX Hedge Fund Activity: Q1 2025 in Review

135 of the 7,470 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q1 2025, worth a combined $362M — down 24% from $474M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of SRDX and 20 opened new positions — a net loss of 3 holders — while 46 trimmed existing stakes and 41 added.

The largest buyer was Soleus Capital Management, adding an estimated $13.3M. The largest seller was Trigran Investments, exiting entirely with an estimated $14.6M sold.

  • 135 institutional investors held Surmodics (SRDX) as of Q1 2025, down from 139 in Q4 2024.
  • Funds reported $362M of Surmodics stock for Q1 2025, down 24% quarter-over-quarter.
  • 20 funds opened new Surmodics positions in Q1 2025 and 23 closed out, a net change of -3 holders.
  • The largest Surmodics buyer in Q1 2025 was Soleus Capital Management, an estimated $13.3M added.
  • The largest Surmodics seller in Q1 2025 was Trigran Investments, an estimated $14.6M sold.

Based on aggregated 13F filings for Q1 2025.